Please note: full product details will be shown on our training portal IPI Academy where you can find out more and book
4-5 Nov 2025 - London
Learn how to enhance your abilities as an HR business partner and deliver support and a positive impact across any business.
Presented by Katie Botten (bio)
12 May 2026 - London
This intensive one-day course will give you many insights into the best practice of organising and conducting an efficient and thorough IP due diligence project.
13 May 2026 - London
An intensive update on patent protection for software-related inventions covering all the major developments in European patent law.
15-18 Jun 2026 - London
This practical four-day course provides a comprehensive understanding of veterinary medicine development in the EU and USA.
24-25 Jun 2026 - London
This seminar combines one day of claim drafting fundamentals with a further day of focused workshops.
15-16 Sep 2026 - London
This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development, or need to provide the regulators with specific usability data for their device.
30 Sep-1 Oct 2026 - London
This annual update, specifically designed for senior trade mark and design administrators, includes the latest updates from WIPO with discussion on the Madrid and Hague systems and a review of the differences between US, EU and UK practice and what to do about them.
Presented by
Xiaodan Dai (bio)
and 7 more leading experts
13 Nov 2026 - London
This course focuses on the drafting skills and legal and commercial issues to be considered when drawing up international IP agreements.
19-20 Nov 2026 - London
Presentations will cover the regulatory framework, pharmaceutical, toxicological and pharmacological data, safety risk assessments, pre-clinical and clinical data, critical expert reports and regulatory submissions.
24-25 Nov 2026 - London
This seminar will take many aspects of animal health and veterinary research and development through a typical clinical trial, and pay attention to compliance with Good Clinical Practice (GCP) as outlined in the two guidelines on safety and efficacy produced by FEDESA and the CVMP.